These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 26432020)
21. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath. Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018 [TBL] [Abstract][Full Text] [Related]
22. Breathomics in lung disease. van der Schee MP; Paff T; Brinkman P; van Aalderen WMC; Haarman EG; Sterk PJ Chest; 2015 Jan; 147(1):224-231. PubMed ID: 25560860 [TBL] [Abstract][Full Text] [Related]
23. Progress in the development of volatile exhaled breath signatures of lung cancer. Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541 [TBL] [Abstract][Full Text] [Related]
25. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label. de Vries R; Dagelet YWF; Spoor P; Snoey E; Jak PMC; Brinkman P; Dijkers E; Bootsma SK; Elskamp F; de Jongh FHC; Haarman EG; In 't Veen JCCM; Maitland-van der Zee AH; Sterk PJ Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326334 [TBL] [Abstract][Full Text] [Related]
26. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study. Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170 [TBL] [Abstract][Full Text] [Related]
27. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. Bos LD; van Walree IC; Kolk AH; Janssen HG; Sterk PJ; Schultz MJ J Appl Physiol (1985); 2013 Nov; 115(10):1487-95. PubMed ID: 23908314 [TBL] [Abstract][Full Text] [Related]
28. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children. Alkhouri N; Cikach F; Eng K; Moses J; Patel N; Yan C; Hanouneh I; Grove D; Lopez R; Dweik R Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):82-7. PubMed ID: 24284369 [TBL] [Abstract][Full Text] [Related]
29. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Sun X; Shao K; Wang T Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028 [TBL] [Abstract][Full Text] [Related]
30. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610 [TBL] [Abstract][Full Text] [Related]
32. Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review. Peel AM; Wilkinson M; Sinha A; Loke YK; Fowler SJ; Wilson AM Respir Med; 2020 Aug; 169():105984. PubMed ID: 32510334 [TBL] [Abstract][Full Text] [Related]
33. Taking your breath away: metabolomics breathes life in to personalized medicine. Rattray NJ; Hamrang Z; Trivedi DK; Goodacre R; Fowler SJ Trends Biotechnol; 2014 Oct; 32(10):538-48. PubMed ID: 25179940 [TBL] [Abstract][Full Text] [Related]
34. Exhaled Biomarkers for Point-of-Care Diagnosis: Recent Advances and New Challenges in Breathomics. Kiss H; Örlős Z; Gellért Á; Megyesfalvi Z; Mikáczó A; Sárközi A; Vaskó A; Miklós Z; Horváth I Micromachines (Basel); 2023 Feb; 14(2):. PubMed ID: 36838091 [TBL] [Abstract][Full Text] [Related]
35. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air. Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084 [TBL] [Abstract][Full Text] [Related]
36. Metabolomics in asthma: where do we stand? Pité H; Morais-Almeida M; Rocha SM Curr Opin Pulm Med; 2018 Jan; 24(1):94-103. PubMed ID: 29059088 [TBL] [Abstract][Full Text] [Related]
37. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
38. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. van der Schee MP; Palmay R; Cowan JO; Taylor DR Clin Exp Allergy; 2013 Nov; 43(11):1217-25. PubMed ID: 24152154 [TBL] [Abstract][Full Text] [Related]
39. Advancing Breathomics through Accurate Discrimination of Endogenous from Exogenous Volatiles in Breath. Cen Z; Huang Y; Li S; Dong S; Wang W; Li X Environ Sci Technol; 2024 Oct; 58(42):18541-18553. PubMed ID: 39340814 [TBL] [Abstract][Full Text] [Related]
40. Breathomics for Gastric Cancer Classification Using Back-propagation Neural Network. Daniel DA; Thangavel K J Med Signals Sens; 2016; 6(3):172-82. PubMed ID: 27563574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]